Bicycle Therapeutics plc
Last updated September 27, 2026
Organization details
- Legal name
- Bicycle Therapeutics plc
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- United Kingdom
- Headquarters city
- Cambridge
- Headquarters country
- United Kingdom
- Fiscal year end
- December
- Ticker symbol
- BCYC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001761612
Board of directors
-
Alessandro Riva · DirectorSince 2025
- Since 2024
-
Gregory Paul Winter · DirectorSince 2023
-
Herve Hoppenot · DirectorSince 2025
-
Janice Bourque · DirectorSince 2023
-
Jose-Carlos Gutierrez-Ramos · DirectorSince 2023
- Since 2024
-
Kevin Lee · Director · CHIEF EXECUTIVE OFFICERSince 2023
-
Pierre Legault · DirectorSince 2023
-
Richard N. Kender · DirectorSince 2023
-
Robert Charles Swanton · DirectorSince 2025
-
Roger D. Dansey · DirectorSince 2025
-
Stephen H. Sands · DirectorSince 2024
-
Veronica Gh Jordan · DirectorSince 2023
Chief executives
Kevin Lee
· Chief Executive Officer
Dates unknown
Board connections
7 of this board's directors also sit on 22 other boards.
- via Alessandro Riva, Felix Baker and Julian Baker
- via Felix Baker, Herve Hoppenot and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Felix Baker and Julian Baker
- via Alessandro Riva
- via Roger D. Dansey
- via Richard N. Kender
- via Herve Hoppenot
- via Roger D. Dansey
- via Richard N. Kender
- via Pierre Legault
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $551,657
- 48 sales by 8 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 6, 2026 | Skynner Michael Officer (CHIEF SCIENTIFIC OFFICER) | Open-market sale | −532 | $4.31 | $2,293 |
| Jul 6, 2026 | Kevin Lee Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market sale | −1,737 | $4.31 | $7,486 |
| Jul 6, 2026 | Thompson Travis Alvin Officer (Chief Financial Officer) | Open-market sale | −104 | $4.31 | $448 |
| Jul 6, 2026 | Hannay Michael Charles Ferguson Officer (CHIEF PROD & SUPPLY CHAIN OFF) | Open-market sale | −255 | $4.31 | $1,099 |
| Jul 6, 2026 | Perry Jennifer Scott Officer (Chief Operating Officer) | Open-market sale | −43 | $4.31 | $185 |
| Jul 6, 2026 | Perry Jennifer Scott Officer (Chief Operating Officer) | Open-market sale | −333 | $4.34 | $1,445 |
| Jul 2, 2026 | Skynner Michael Officer (CHIEF SCIENTIFIC OFFICER) | Open-market sale | −1,859 | $4.27 | $7,938 |
| Jul 2, 2026 | Kevin Lee Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market sale | −5,905 | $4.27 | $25,214 |
| Jul 2, 2026 | Thompson Travis Alvin Officer (Chief Financial Officer) | Open-market sale | −819 | $4.27 | $3,497 |
| Jul 2, 2026 | Hannay Michael Charles Ferguson Officer (CHIEF PROD & SUPPLY CHAIN OFF) | Open-market sale | −1,506 | $4.27 | $6,431 |
| Jul 2, 2026 | Perry Jennifer Scott Officer (Chief Operating Officer) | Open-market sale | −1,036 | $4.27 | $4,424 |
| Apr 6, 2026 | Hannay Michael Charles Ferguson Officer (CHIEF PROD & SUPPLY CHAIN OFF) | Open-market sale | −251 | $5.05 | $1,268 |
| Apr 6, 2026 | Thompson Travis Alvin Officer (Chief Financial Officer) | Open-market sale | −102 | $5.05 | $515 |
| Apr 6, 2026 | Perry Jennifer Scott Officer (Chief Operating Officer) | Open-market sale | −37 | $5.05 | $187 |
| Apr 6, 2026 | Kevin Lee Director, Officer (CHIEF EXECUTIVE OFFICER) | Open-market sale | −1,716 | $5.05 | $8,666 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.